Literature DB >> 21526924

Bevacizumab versus ranibizumab for AMD.

Philip J Rosenfeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21526924     DOI： 10.1056/NEJMe1103334

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  [Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Authors:  R W C Janzen; W D Ludwig
Journal:  Z Rheumatol       Date:  2012-02       Impact factor: 1.372

Review 2.  U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.

Authors:  Nadine Shehab; Megan N Brown; Alexander J Kallen; Joseph F Perz
Journal:  J Patient Saf       Date:  2018-09       Impact factor: 2.844

3.  More on a patient-centric approach in the anti-VEGF therapy.

Authors:  A Grzybowski; F J Ascaso
Journal:  Eye (Lond)       Date:  2012-07-20       Impact factor: 3.775

Review 4.  Mobilizing endogenous stem cells for retinal repair.

Authors:  Honghua Yu; Thi Hong Khanh Vu; Kin-Sang Cho; Chenying Guo; Dong Feng Chen
Journal:  Transl Res       Date:  2013-11-22       Impact factor: 7.012

Review 5.  Complement factor H in AMD: Bridging genetic associations and pathobiology.

Authors:  Christopher B Toomey; Lincoln V Johnson; Catherine Bowes Rickman
Journal:  Prog Retin Eye Res       Date:  2017-09-18       Impact factor: 21.198

Review 6.  A literature analysis on anti-vascular endothelial growth factor therapy (anti-VEGF) using a bibliometric approach.

Authors:  Andy Wai Kan Yeung; Mohamed M Abdel-Daim; Abdelrahman Ibrahim Abushouk; Kazuaki Kadonosono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-03-02       Impact factor: 3.000

Review 7.  Clinical pharmacology of intravitreal anti-VEGF drugs.

Authors:  Stefano Fogli; Marzia Del Re; Eleonora Rofi; Chiara Posarelli; Michele Figus; Romano Danesi
Journal:  Eye (Lond)       Date:  2018-02-05       Impact factor: 3.775

Review 8.  Mechanism of inflammation in age-related macular degeneration.

Authors:  Francesco Parmeggiani; Mario R Romano; Ciro Costagliola; Francesco Semeraro; Carlo Incorvaia; Sergio D'Angelo; Paolo Perri; Paolo De Palma; Katia De Nadai; Adolfo Sebastiani
Journal:  Mediators Inflamm       Date:  2012-11-07       Impact factor: 4.711

9.  Dynamic increase in extracellular ATP accelerates photoreceptor cell apoptosis via ligation of P2RX7 in subretinal hemorrhage.

Authors:  Shoji Notomi; Toshio Hisatomi; Yusuke Murakami; Hiroto Terasaki; Shozo Sonoda; Ryo Asato; Atsunobu Takeda; Yasuhiro Ikeda; Hiroshi Enaida; Taiji Sakamoto; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

10.  Comparison of systemic adverse events associated with intravitreal anti-VEGF injection: ranibizumab versus bevacizumab.

Authors:  Duck Jin Hwang; Yong Woo Kim; Se Joon Woo; Kyu Hyung Park
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.